These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6881023)

  • 1. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of ventricular arrhythmias with intravenous disopyramide and lidocaine: efficacy comparison in a randomized trial.
    Sbarbaro JA; Rawling DA; Fozzard HA
    Am J Cardiol; 1979 Sep; 44(3):513-20. PubMed ID: 474432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous disopyramide: safety and efficacy of a new dosage regimen.
    Reddy CP; Benes J; Beck B
    Clin Pharmacol Ther; 1984 May; 35(5):610-6. PubMed ID: 6713772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetics of hemodynamic and electrocardiographic changes following intravenous disopyramide.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1979; 205(5):417-23. PubMed ID: 443082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of an anti-arrhythmic agent, disopyramide, in delayed action form ('Ritmoforine' Retard).
    Nauta IL; van de Calseyde JF
    Curr Med Res Opin; 1981; 7(4):215-26. PubMed ID: 7226872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiologic study of disopyramide].
    Ponsonnaille J; Marcheix JC; Datchary J; Gras H
    Ann Cardiol Angeiol (Paris); 1979; 28(1):49-52. PubMed ID: 434759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute oral antiarrhythmic testing with disopyramide.
    García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
    Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release disopyramide compared to plain capsules after change-over from intravenous infusion.
    Lien E; Bakke OM
    Br J Clin Pharmacol; 1983 Jul; 16(1):71-6. PubMed ID: 6882625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic action of disopyramide: a study of plasma levels].
    Page A; Pic A; Besse P
    Arch Mal Coeur Vaiss; 1979 Jul; 72(7):774-80. PubMed ID: 117775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy after i.v. administration of disopyramide with an oral sustained release preparation, a pharmacokinetic study.
    Liem KL; Hollander JM
    Br J Clin Pharmacol; 1984 Aug; 18(2):226-8. PubMed ID: 6487461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.